Conning Capital Partners
8
13M
5
0.38
4
- Areas of investment
Summary
The venture was found in North America in United States. The leading representative office of defined VC is situated in the Hartford.
The increased amount of exits for fund were in 2016. The fund is generally included in less than 2 deals every year. Opposing the other organizations, this Conning Capital Partners works on 21 percentage points more the average amount of lead investments. Deals in the range of 10 - 50 millions dollars are the general things for fund. The high activity for fund was in 2001. Considering the real fund results, this VC is 5 percentage points more often commits exit comparing to other organizations.
The overall number of key employees were 1.
Moreover, a startup needs to be at the age of 6-10 years to get the investment from the fund. Among the most successful fund investment fields, there are Small and Medium Businesses, Health Care. For fund there is a match between the location of its establishment and the land of its numerous investments - United States. Among the most popular portfolio startups of the fund, we may highlight Neovest Holdings, AnnuityNet, Vantage Oncology.
The standard case for the fund is to invest in rounds with 3-4 partakers. Despite the Conning Capital Partners, startups are often financed by Versant Ventures, Salix Ventures, New Enterprise Associates. The meaningful sponsors for the fund in investment in the same round are Versant Ventures, Salix Ventures, New Enterprise Associates. In the next rounds fund is usually obtained by New Enterprise Associates, Versant Ventures, Salix Ventures.
Investments analytics
Analytics
- Total investments
- 8
- Lead investments
- 0
- Exits
- 4
- Follow on index
- 0.38
- Investments by industry
- Health Care (4)
- Biotechnology (4)
- Health Diagnostics (4)
- Internet (2)
- Financial Services (2) Show 7 more
- Investments by region
-
- United States (8)
- Peak activity year
- 2001
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 27
- Avg. valuation at time of investment
- 139M
- Group Appearance index
- 0.88
- Avg. company exit year
- 16
- Avg. multiplicator
- 5.68
- Strategy success index
- 0.30
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|---|---|---|---|---|
| Vantage Oncology | 10 May 2005 | Biotechnology, Health Care, Health Diagnostics | Late Stage Venture | 22M | United States, California |
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.